Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-101897
Filing Date
2024-09-23
Accepted
2024-09-23 08:20:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A tm2423565d2_s1a.htm S-1/A 371432
2 EXHIBIT 23.1 tm2423565d2_ex23-1.htm EX-23.1 2765
3 GRAPHIC tm2423565d1_s1img001.jpg GRAPHIC 9731
4 GRAPHIC tm242356_5d2s1aimg003.jpg GRAPHIC 60231
  Complete submission text file 0001104659-24-101897.txt   472224
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-282024 | Film No.: 241314686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)